Label: NEUTRAL SODIUM FLUORIDE 0.2% DENTAL RINSE- sodium fluoride rinse
- NDC Code(s): 60258-158-16
- Packager: Cypress Pharmaceutical, Inc.
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
If you are a consumer or patient please visit this version.
- Neutral Sodium Fluoride 0.2% Dental Rinse
Neutral Sodium Fluoride 0.2%
Cypress Pharmaceutical, Inc.
16 fl oz (1 pt) (473 mL)
Description: Neutral Sodium Fluoride 0.2% Dental Rinse is a mint-flavored, neutral, aqueous solution containing 6% alcohol.
ACTIVE INGREDIENT: Sodium Fluoride 0.2% (w/v). Contains: FD and C Blue #1.
INACTIVE INGREDIENT: Purified water, Glycerin, Alcohol 6% (v/v), Xylitol, Sodium Benzoate, Flavor, Magna Sweet, FD and C Blue #1.
CLINICAL PHARMACOLOGY: Topical application of sodium fluoride increases tooth resistance to acid dissolution, promotes remineralzation, and inhibits the cariogenic microbial process.
INDICATIONS AND USAGE: For once-weekly use as a dental caries preventative in pediatric patients.
WARNINGS: DO NOT SWALLOW. Keep out of reach of infants and children.
DOSAGE AND ADMINISTRATION: For caries- Adults and pediatric patients over 6 years, 2 teaspoonfuls (10mL) once a week, preferably at bedtime after thoroughly brushing teeth, rinse vigorously around and between teeth for one minute, then expectorate. DO NOT SWALLOW. For maximum benefit, do not eat, drink, or rinse mouth for at least 30 minutes after treatment.
STORAGE: Store at controlled room temperature, 20-25oC (68-77oF).
See package insert for additional information.
Cypress Pharmaceutical, Inc.,
Madison, MS 39110
Neutral Sodium Fluoride 0.2% Dental Rinse is a mint-flavored, neutral, aqueous solution containing 6% alcohol.Close
Active ingredient: Sodium Fluoride 0.2% (w/v). Contains: FD and C Blue #1.
Inactive ingredients: Purified water, Glycerin, Alcohol 6% (v/v), Xylitol, Sodium Benzoate, Flavor, Magna Sweet, FD and C Blue #1.
- CLINICAL PHARMACOLOGY
Topical application of sodium fluoride increases tooth resistance to acid dissolution, promotes remineralzation, and inhibits the cariogenic microbial process. Close
- INDICATIONS AND USAGE
A dental caries preventative for weekly self-applied topical use. Weekly rinsing with a neutral 0.2% sodium fluoride solution protects against dental caries in pediatric patients. Neutral Sodium Fluoride 0.2% Dental Rinse provides a ready- to-use preparation for convenient administration and favorable compliance. May be used in areas where drinking water is fluoridated since topical fluoride cannot produce fluorosis. (See WARNINGS for exception.)Close
Do not use in patients with dyaphagia. Do not use in pediatric patients under age 6 years unless recommended by a dentist or physician.
Keep out of reach of infants and children. Pediatric patients under age 12 should be supervised in the use of this product. Patients under age 6 require special supervision to prevent repeated swallowing of rinse since they frequently swallow significant amounts while rinsing. Prolonged daily ingestion may result in dental fluorosis in patients under age 6, especially if water fluoridation exceeds 0.6 ppm. Read directions carefully before using.Close
General: Not for systemic treatment. DO NOT SWALLOW.Close
- Carcinogenesis, Mutagenesis, and Impairment of Fertility
No carcinogenesis was found in mice or female rats treated with fluoride at doses ranging from 4.1 to 9.1 mg/kg of body weight. Equivocal evidence of carcinogenesis was reported in rats treated with 2.5 and 4.1 mg/kg of body weight. In another study, no carcinogenesis was observed in rats treated with fluoride up to 11.3 mg/kg of body weight. Epidemiological data provide no credible evidence for an association between fluoride, either naturally occurring or added to drinking water, and risk of human cancer.Close
Fluoride ion is not mutagenic in standard bacterial systems but has been associated with chromosome aberrations in cultured human and rodent cells at doses much higher than expected human exposures. Some in vivo studies report chromosome damage in rodents while other studies using similar protocols report negative results.
Potential adverse reproductive effects of fluoride exposure in humans has not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in rats demonstrated that lower concentrations of fluoride (5 mg/kg of body weight) did not result in impaired fertility and reproductive capabilities.
Teratogenic Effects: Pregnancy Category B. It has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissue. Animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. Maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect litter size or fetal weight and did not increase frequency of skeletal or visceral malformations. There are no adequate and well-controlled studies in pregnant women. However, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. Heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in childhood.Close
- Nursing Mothers
It is not known if fluoride is excreted in human milk. However, many drugs are excreted in milk and caution should be exercised when products containing fluoride are administered to a nursing woman. Reduced milk production was reported in farm-raised fox when the animals were fed a diet containing a high concentration of fluoride (98-137 mg/kg of body weight). No adverse effects on parturition, lactation, or offspring were seen in rats administered fluoride up to 5 mg/kg of body weight.Close
- Pediatric Use
The use of Neutral Sodium Fluoride 0.2% Dental Rinse as a weekly caries preventative in pediatric patients aged 6 to 16 years is supported by adequate and well-controlled clinical studies in students aged 6 to 12 years.1-3 Safety and effectiveness in pediatric patients below the ages of 6 years have not been established. Please refer to the CONTRAINDICATIONS and WARNINGS sections.Close
- Geriatric Use
Of the total number of subjects in clinical studies of 1.1% (w/v) sodium fluoride, 15 percent were 65 and over, while 1 percent were 75 and over. No overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients but greater sensitivity of some older individuals cannot be ruled out. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.Close
- ADVERSE REACTIONS
In patients with mucositis, gingival tissues may be hypersensitive to flavor or alcohol present in formulation. Allergic reactions and other idiosyncrasies are rarely reported.Close
Accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue. Nausea, vomiting, and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salivation, hematemesis and epigastric cramping abdominal pain. These symptoms may persist for 24 hours. If less than 5 mg fluoride/kg body weight (i.e. less than 2.3 mg fluoride/lb body weight)has been ingested, give calcium (e.g. milk) orally to relieve gastrointestinal symptoms and observe for a few hours. If more than 5 mg fluoride/kg body weight (i.e. more than 2.3 mg fluoride/lb body weight) has been ingested, induce vomiting give orally soluble calcium (e.g.milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance. For accidental ingestion of more than 15 mg fluoride/kg of body weight (i.e. more than 6.9 mg fluoride/lb body weight) induce vomiting and admit immediately to a hospital facility.
A treatment dose (10 mL or two teaspoonfuls) of Neutral Sodium Fluoride 0.2% Dental Rinse contains approximately 9 mg of fluoride one 16 fl oz bottle contains approximately 429 mg fluoride. Close
- DOSAGE AND ADMINISTRATION
For caries- Adults and pediatric patients over age 6 years, 2 teaspoonfuls (10mL) once a week, preferably at bedtime after thoroughly brushing teeth, rinse vigorously around and between teeth for one minute, then expectorate. DO NOT SWALLOW. For maximum benefit, do not eat, drink, or rinse mouth for at least 30 minutes afterwards.Close
- HOW SUPPLIED
Plastic bottle with child-resistant closure containing 16 fl oz (473 mL) (NDC 60258-158-16).Close
Store at Controlled Room Temperature, 20-25oC (68-77oF).Close
1. American Dental Association, Accepted Dental Therapeutics,
Ed. 40, Chicago(1984): 403. 2. Ibid., p. 405-407. 3. L.W. Ripa, G.S.
Leske, and A. Sposato, "Supervised Weekly Rinsing with a 0.2% Neutral
NaF Solution: Final Results of a Demonstration Program after Six School
Years" J. Pub. Health Dent, 43 (1983):
53-62. 4. Driscoll WS, et al. "Caries- preventative effects on school
children daily and weekly fluoride mouthrinsing in a fluoridated
community: final results after 30 months" JADA. 1982;105:1010-1013.
Cypress Pharmaceutical, Inc.
Cypress Pharmaceutical, Inc.,
Madison, MS 39110
- INGREDIENTS AND APPEARANCE
NEUTRAL SODIUM FLUORIDE 0.2% DENTAL RINSE
sodium fluoride rinse
Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:60258-158 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SODIUM FLUORIDE (FLUORIDE ION) SODIUM FLUORIDE 9 mg in 10 mL Product Characteristics Color Score Shape Size Flavor MINT Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:60258-158-16 473 mL in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved other 08/01/2006 Labeler - Cypress Pharmaceutical, Inc. (790248942) Registrant - Cypress Pharmaceutical, Inc. (790248942) Establishment Name Address ID/FEI Business Operations Emerald 3 Enterprises, Inc. 000000000 manufacture